Circulating molecular markers in pancreatic cancer: ready for clinical use?

Author： Gall Tamara MH   Frampton Adam E   Krell Jonathan   Castellano Leandro   Jiao Long R  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.9, Iss.2, 2013-02, pp. : 141-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular and clinical risk markers in colon cancer trials

By Hill M.J.  

European Journal of Cancer, Vol. 36, Iss. 10, 2000-06 ,pp. : 1288-1291

Elsevier

Access to resources Recommend Favorite

Clinical relevance of molecular markers in lung cancer

By Iyengar P.   Tsao M.-S.  

Surgical Oncology, Vol. 11, Iss. 4, 2002-12 ,pp. : 167-179

Elsevier

Access to resources Recommend Favorite

Molecular markers in colorectal cancer: clinical relevance in stage II colon cancer

By Santos Cristina   Vilar Eduardo   Capella Gabriel   Salazar Ramon  

Colorectal Cancer, Vol. 2, Iss. 3, 2013-06 ,pp. : 243-263

Future Medicine

Access to resources Recommend Favorite

Circulating miR-17-5p and miR-20a: Molecular markers for gastric cancer

By                  

Molecular Medicine Reports, Vol. 5, Iss. 6, 2012-01 ,pp. : 1514-1520

Spandidos Publications

Access to resources Recommend Favorite

The Use of Molecular Markers in Farnesyltransferase Inhibitor (FTI) Therapy of Breast Cancer

By Moasser M.M.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 2, 2002-05 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite